Extensive clinical practice has shown that administering high-dose radiation or chemotherapy to patients in the middle to late stages of cancer—or re-administering chemotherapy to those who have developed drug resistance—often leads only to further weakening of an already frail patient, accelerating their decline and ultimately hastening death. Biological therapies, however, can effectively address the limitations of conventional treatments such as surgery, radiation, and chemotherapy. Not only do they enhance the efficacy of radio- and chemotherapy, but they also help mitigate the toxic side effects associated with these therapies. More importantly, biological treatments work by disrupting the replication mechanisms of cancer cells—specifically by inhibiting the synthesis of tubulin, a critical protein involved in cell division. This process gradually reduces the size of cancer cells, enabling them to form stable anti-cancer entities within blood vessels. As a result, the body’s metabolic functions are improved, effectively suppressing cancer cell respiration, depriving them of essential nutrients like oxygen and blood supply, and halting their ability to divide. Ultimately, this approach paves the way for a potential cure. For more information, please contact the Taixinsheng hotline at 010-51571020.